Xembify

Xembify is a human normal immunoglobulin solution for subcutaneous use, prescribed for immune deficiencies. This therapy supports antibody levels in patients with primary immunodeficiency. It is administered under medical guidance. Xembify provides passive immunity support.

Xembify is used to treat primary immunodeficiency disorders where the body's immune system is weakened. It helps maintain adequate antibody levels to prevent infections. This medication is prescribed for conditions like common variable immunodeficiency or X-linked agammaglobulinemia. Xembify supports immune function by providing normal immunoglobulins.

Xembify works by supplementing the body's natural antibodies, which helps strengthen the immune response. Patients may experience improved resistance to common infections over time. The effects are gradual as the body adjusts to the therapy. Regular use is typically required to maintain benefits.

Xembify should be stored refrigerated and protected from freezing. Patients should follow their healthcare provider's instructions for administration and monitoring. Report any signs of infection or adverse reactions promptly. Avoid altering the dose without medical advice.

Xembify may interact with live vaccines, potentially reducing their effectiveness. Consult a healthcare provider before receiving vaccinations. Certain medications, such as immunosuppressants, may affect how Xembify works. Always inform your doctor about all medications being taken.